📍Need-to-Know Pathology: A Review for Physicians in a Hurry 2023
Expert speakers deliver a high-yield review of a comprehensive array of head-to-toe anatomic pathology topics in this continuing medical education program. They also delve into the nuts and bolts of running a multidisciplinary clinical pathology laboratory with support for highly specialized testing.
📍Need-to-Know Pathology: A Review for Physicians in a Hurry 2023
Expert speakers deliver a high-yield review of a comprehensive array of head-to-toe anatomic pathology topics in this continuing medical education program. They also delve into the nuts and bolts of running a multidisciplinary clinical pathology laboratory with support for highly specialized testing.
At a time when the Indian stock market is peaking and has rallied immensely compared to global markets, there are companies that have not performed in the last 10 years. These are definitely a minor portion of the market considering there are hundreds of stocks that have turned multibagger since 2020. What went wrong with these stocks? Reasons vary from corporate governance, sectoral weakness, company specific and so on. But the more important question is, are these stocks worth buying?
In many cases, the content resembled that of the marketplaces found on the dark web, a group of hidden websites that are popular among hackers and accessed using specific anonymising software.“We have recently been witnessing a 100 per cent-plus rise in Telegram usage by cybercriminals,” said Tal Samra, cyber threat analyst at Cyberint.The rise in nefarious activity comes as users flocked to the encrypted chat app earlier this year after changes to the privacy policy of Facebook-owned rival WhatsApp prompted many to seek out alternatives.telegram from us
